Life Science Company News

Disclosure of received notifications

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 9 July 2020

Disclosure of received notifications

Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of Norges Bank.

Notifications of Norges Bank

  • On 6 July 2020, Fagron received a notification of Norges Bank that the number of directly held voting rights had fallen below the disclosure threshold of 3% on 3 July 2020 as the result of the disposal of voting securities or voting rights.
3 July 2020  
Voting rights2,118,7912.94%
Equivalent financial instruments (right to recall)281,0150.39%
Total number of voting rights2,399,8063.32%
  • On 7 July 2020, Fagron received a notification of Norges Bank that the number of directly held voting rights had crossed the disclosure threshold of 3% on 6 July 2020 as the result of the acquisition of voting securities or voting rights.
6 July 2020  
Voting rights2,242,4273.11%
Equivalent financial instruments (right to recall)281,0150.39%
Total number of voting rights2,523,4423.50%
  • On 8 July 2020, Fagron received a notification of Norges Bank that the number of directly held voting rights had fallen below the disclosure threshold of 3% on 7 July 2020 as the result of the disposal of voting securities or voting rights.
7 July 2020  
Voting rights2,043,1202.83%
Equivalent financial instruments (right to recall)288,9430.40%
Total number of voting rights2,332,0633.23%
  • The notifications of Norges Bank can be viewed on investors.fagron.com via this link.

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.

For more information
Constantijn van Rietschoten
Chief Communications Officer
Tel. +31 6 53 69 15 85
constantijn.van.rietschoten@fagron.com

Please open the link below for the press release:
Disclosure of received notification


By: GlobeNewswire - 09 Jul 2020
Back to overview

Enhance your business development with Biotechgate